Experimental study on the correlation between Bim and acquired drug resistance in the patients with EGFR-sensitive mutant lung adenocarcinoma after gefitinib first-line treatment

GAO Junzhen; LIU Yanfang; WANG Lihong

doi:10.3969/j.issn.1002-7386.2020.08.018

Home>Articles>Experimental study on the correlation between Bim and acquired drug resistance in the patients with EGFR-sensitive mutant lung adenocarcinoma after gefitinib first-line treatment

DOI: 10.3969/j.issn.1002-7386.2020.08.018

Experimental study on the correlation between Bim and acquired drug resistance in the patients with EGFR-sensitive mutant lung adenocarcinoma after gefitinib first-line treatment

GAO Junzhen

LIU Yanfang

WANG Lihong

Machine-generated Keywords：

Publication Date：2020-04-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1196-1198,1202 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2020,42(8)